申请人:Gilead Sciences, Inc.
公开号:US20180298025A1
公开(公告)日:2018-10-18
The present disclosure provides solid forms, including a salt or co-crystal, of Compound I:
which exhibits Acetyl-CoA carboxylase (“ACC”) inhibitory activity and may be useful in treating ACC mediated diseases. Also provided herein are processes or steps for the preparation of a Compound I and intermediates useful for the processes or steps described herein.